Legal Opinion
United States ex rel. Vierczhalek v. Medimmune, Inc.
District Court, S.D. Illinois
Decided September 28, 2018No. 09 Civ. 3919 (RJS)PublishedCited by 4 opinions
1Opinion of the Court
RICHARD J. SULLIVAN, United States District Judge
Susan Vierczhalek, a medical doctor, brings this qui tam action against Defendant MedImmune, Inc. ("MedImmune"), the manufacturer of a drug called Synagis, which is prescribed to prevent lung infections in premature infants. Vierczhalek alleges that MedImmune violated federal and state law in its effort to increase sales of the drug. Now before the Court is MedImmune's motion to dismiss Vierczhalek's amended complaint (the "Amended Complaint"). (Doc. No. 126.) For the reasons discussed below, that motion is GRANTED.
I. BACKGROUND 1
Vierczhalek is…
2Cases cited22 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Natalia Makarova v. United StatesCourt of Appeals for the Second Circuit · 2000
- ATSI Communications, Inc. v. Shaar Fund, Ltd.Court of Appeals for the Second Circuit · 2007
- Morrison v. National Australia Bank Ltd.Court of Appeals for the Second Circuit · 2008
17 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- United States of America ex rel. John R. Borzilleri, M.D. v. Abbvie, Inc.District Court, S.D. New York · 2019
- United States of America ex rel. NPT Associates v. Laboratory Corporation of America HoldingsDistrict Court, S.D. New York · 2022
- United States v. Fresenius Medical Care AG & Co. KGAADistrict Court, E.D. New York · 2021
- Vierczhalek v. MedImmuneCourt of Appeals for the Second Circuit · 2020